Maija Lappalainen

Maija Lappalainen

Auto-generated profile, based on publicly available information

Maija Lappalainen

HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2020 in Eurosurveillance
Verified
Journal Article
Open access
AHAnu Haveri
Anu Haveri
TSTeemu Smura
Teemu Smura
SKSuvi Kuivanen
Suvi Kuivanen
PÖPamela Österlund
Pamela Österlund
JHJussi Hepojoki
Jussi Hepojoki
CSCarita Savolainen-Kopra
Carita Savolainen-Kopra
The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020. No secondary cases were detected. We describe the clinical picture and laboratory findings 3–23 days since the first symptoms. The SARS-CoV-2/Finland/1/2020 virus strain was isolated, the genome showing a single nucleotide substitution to the reference strain from Wuhan. Neutralising antibody response appeared within 9 days along with specific IgM and IgG response, targeting particularly nucleocapsid and spike proteins.

16 August 2010 in Epidemiology and Infection
Verified
Journal Article
Closed access
PDF file
MIMiren Iturriza-Gomara
Miren Iturriza-Gomara
TDT. Dallman
T. Dallman
Krisztian BanyaiKrisztian Banyai
Krisztian Banyai
BBB. Böttiger
B. Böttiger
Javier BuesaJavier Buesa
Javier Buesa
JGJ. Gray
J. Gray
SUMMARY: EuroRotaNet, a laboratory network, was established in order to determine the diversity of co-circulating rotavirus strains in Europe over three or more rotavirus seasons from 2006/2007 and currently includes 16 countries. This report highlights the tremendous diversity of rotavirus strains co-circulating in the European population during three years of surveillance since 2006/2007 and points to the possible origins of these strains including genetic reassortment and interspecies transmission. Furthermore, the ability of the network to identify strains circulating with an incidence of ⩾1% allowed the identification of possible emerging strains such as G8 and G12 since the beginning of the study; analysis of recent data indicates their increased incidence. The introduction of universal rotavirus vaccination in at least two of the participating countries, and partial vaccine coverage in some others may provide data on diversity driven by vaccine introduction and possible strain replacement in Europe.

1 August 2020 in Journal of Clinical Virology
Verified
Journal Article
Closed access
AJAj Jääskeläinen
Aj Jääskeläinen
SKSuvi Kuivanen
Suvi Kuivanen
EKE Kekäläinen
E Kekäläinen
MAMj Ahava
Mj Ahava
RLR Loginov
R Loginov
MLM Lappalainen
M Lappalainen

1 February 2006 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
BEB. Edvinsson
B. Edvinsson
MLM. Lappalainen
M. Lappalainen
BEB. Evengård
B. Evengård
Sensitive and rapid detection of infection with Toxoplasma gondii in transplanted immunocompromised patients is crucial for a good prognosis. Two DNA fragments are used currently for detecting T. gondii infection by PCR, i.e., the B1 gene and a 529-bp repeat element that exists in 200-300 copies/genome. This study investigated whether targeting the 529-bp repeat element gives better sensitivity and accuracy than can be obtained when targeting the B1 gene (35 copies) when concentrations of T. gondii DNA are low. The results demonstrated that detection of the 529-bp repeat element increased diagnostic sensitivity and accuracy. Addition of an internal amplification control did not affect the PCR performance and was useful in order to monitor PCR inhibition by non-specific DNA in the LightCycler instrument. The real-time PCR was used successfully in a clinical context to monitor parasitaemia in the blood of a transplant recipient suffering from toxoplasmosis.

22 March 2011 in Epidemiology and Infection
Verified
Journal Article
Closed access
PDF file
ESE. Sarvikivi
E. Sarvikivi
MRM. Roivainen
M. Roivainen
LML. Maunula
L. Maunula
TNT. Niskanen
T. Niskanen
TKT. Korhonen
T. Korhonen
MKM. Kuusi
M. Kuusi
SUMMARY: In 2009, the number of foodborne norovirus outbreaks in Finland seemed markedly high, and many outbreaks seemed to be linked to imported frozen raspberries. We reviewed the data regarding all notified foodborne outbreaks in 2009 in Finland in order to assess the magnitude of the problem and to summarize the information on raspberry–linked outbreaks. Between March and August, 13 norovirus outbreaks affecting about 900 people could be linked to imported frozen raspberries. Two raspberry samples corresponding to two batches of raspberries were positive for norovirus. These two batches proved to have been the likely source in six of the 13 outbreaks. Analytical studies had not been conducted for six outbreaks, and virological test results were inconclusive in two. However, combining epidemiological and microbiological methods often enabled finding the source, as exemplified in investigation of a large school outbreak. To ensure prompt control measures in similar situations in the future, both aspects of outbreak investigations should be strengthened.

21 October 2011 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
TMTimi Martelius
Timi Martelius
MLMaija Lappalainen
Maija Lappalainen
MPMaarit Palomäki
Maarit Palomäki
VAVeli-Jukka Anttila
Veli-Jukka Anttila
The role of Epstein-Barr (EBV) virus in central nervous system (CNS) infections is not fully resolved. It is clearly associated with lymphoproliferative disease of immunosuppressed persons, and may cause encephalitis.